Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Treatment for preleukemic disorder from Milkhaus enters phase III

Sep. 9, 1997

GeneMedicine begins phase I testing of IL-2 Cancer Gene Medicine

Sep. 8, 1997

Novel integrin receptor antagonists from DuPont Merck

Sep. 8, 1997

Antimitotic cryptophycin compounds

Sep. 5, 1997

Vitamin D derivatives as progesterone antagonists

Sep. 5, 1997

New antitumor agents from Kyorin and Sagami

Sep. 5, 1997

DepoTech seeks Canadian approval for DepoCyt

Sep. 4, 1997

AccuSite approved in Ireland and The Netherlands

Sep. 4, 1997

Vitronectin receptor antagonists described by Merck KGaA

Sep. 4, 1997

Cloning of telomerase catalytic subunit reported

Sep. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...